Breast cancer is one of the most common neoplastic pathology in females.1 Every year in Italy more than 47,000 new breast cancer cases are diagnosed.1, 2 Thanks to a growing social sensitization of the problem,3 to the new diagnostic devices 4 – that allow an early diagnosis – and to the new therapeutic options a rising number of patients is successfully treated. Surgery is, for most of the patients, a forced step to face during treatment for breast cancer and the type of surgery 5 depends on the extension of the tumour itself. Madden’s modi ed radical mastectomy 6 is still the standard surgical treatment for patients with breast cancer non suitable for conservative surgical treatment. Differently, in cases of less advanced stages, conservative surgical treatment, as segmental mastectomy or quadrantectomy with sentinel lymphnode biopsy and/or axillary dissection remains the favourite therapeutic options for patients needing surgery. Although the mortality rate is decreasing and we’re assisting to an increasing survival rate, the number of patients suffering of issues surgeryrelated is rising